Globus Medical (GMED) Short term Debt (2011 - 2024)

Globus Medical's (GMED) quarterly Short term Debt came in at $443.4 million in Q4 2024, up 1.42% quarter-over-quarter from $437.1 million in Q3 2024.

Analysis

Globus Medical (GMED) Short term Debt (2011 - 2024) Analysis & Trends

Globus Medical (GMED) has reported Short term Debt for 5 consecutive years, with $443.4 million the latest figure, recorded in Q4 2024.

For the quarter ending Q4 2024, Short term Debt changed N/A year-over-year to $443.4 million; the trailing twelve-month figure through Dec 2024 stood at $443.4 million (changed N/A YoY), and the FY2024 full-year result was $443.4 million, changed N/A from the prior year.
Short term Debt advanced to $443.4 million in Q4 2024 per GMED's latest filing, from $437.1 million in the prior quarter.
Across five years, Short term Debt topped out at $443.4 million in Q4 2024 and bottomed at $424.0 million in Q1 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	180.78 Bn	175.17 Bn	7.27 Bn
2	Intuitive Surgical	127.04 Bn	121.82 Bn	1.96 Bn
3	Medtronic	117.04 Bn	108.22 Bn	6.34 Bn
4	Stryker	103.86 Bn	100.38 Bn	4.50 Bn
5	Boston Scientific	63.50 Bn	62.96 Bn	3.85 Bn
6	Edwards Lifesciences	49.74 Bn	45.49 Bn	1.35 Bn
7	Alcon	32.99 Bn	31.53 Bn	1.68 Bn
8	Dexcom	32.12 Bn	30.17 Bn	830.00 Mn
9	Steris	20.69 Bn	20.21 Bn	684.20 Mn
10	Globus Medical	9.98 Bn	9.38 Bn	548.17 Mn

Historic Data

Download Data